- This event has passed.
ddPCR for the Determination of MSI Status in Patients with Cancer
4 February|16:00 - 17:00
Microsatellite instability (MSI) status is routinely assessed in patients with colorectal and endometrial cancers as it contributes to Lynch syndrome initial screening, tumour prognosis, and selecting patients for immunotherapy. Standard reference methods recommended for MSI/dMMR (deficient MisMatch Repair) testing consist of IHC and PCR-based assays, however, novel molecular-based techniques are emerging. During this webinar, Dr Alexandre Harlé will present the results of his performance evaluation of the Bio-Rad ddPCR assay.